UCB SA (UCBJY)
149.57
-1.08
(-0.72%)
USD |
OTCM |
Oct 27, 16:00
UCB Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 19, 2026 | 7.148 |
| October 16, 2026 | 7.164 |
| October 15, 2026 | 7.227 |
| October 14, 2026 | 7.048 |
| October 13, 2026 | 6.934 |
| October 12, 2026 | 7.133 |
| October 09, 2026 | 7.146 |
| October 08, 2026 | 7.116 |
| October 07, 2026 | 7.149 |
| October 06, 2026 | 7.104 |
| October 05, 2026 | 7.072 |
| October 02, 2026 | 7.212 |
| October 01, 2026 | 7.096 |
| September 30, 2026 | 7.260 |
| September 29, 2026 | 7.361 |
| September 28, 2026 | 7.583 |
| September 25, 2026 | 7.676 |
| September 24, 2026 | 7.554 |
| September 23, 2026 | 7.521 |
| September 22, 2026 | 7.623 |
| September 21, 2026 | 7.623 |
| September 18, 2026 | 7.484 |
| September 17, 2026 | 7.494 |
| September 16, 2026 | 7.391 |
| September 15, 2026 | 7.573 |
| Date | Value |
|---|---|
| September 14, 2026 | 7.600 |
| September 11, 2026 | 7.47 |
| September 10, 2026 | 7.327 |
| September 09, 2026 | 7.428 |
| September 08, 2026 | 7.514 |
| September 04, 2026 | 7.659 |
| September 03, 2026 | 8.047 |
| September 02, 2026 | 7.992 |
| September 01, 2026 | 7.90 |
| August 31, 2026 | 7.821 |
| August 28, 2026 | 7.842 |
| August 27, 2026 | 8.063 |
| August 26, 2026 | 8.042 |
| August 25, 2026 | 8.189 |
| August 24, 2026 | 8.043 |
| August 21, 2026 | 8.088 |
| August 20, 2026 | 7.893 |
| August 19, 2026 | 8.014 |
| August 18, 2026 | 7.886 |
| August 17, 2026 | 7.787 |
| August 14, 2026 | 7.673 |
| August 13, 2026 | 7.897 |
| August 12, 2026 | 7.998 |
| August 11, 2026 | 8.165 |
| August 10, 2026 | 8.133 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 35.83 |
| AstraZeneca PLC | 11.11 |
| Corcept Therapeutics, Inc. | 13.21 |
| Jazz Pharmaceuticals Plc | 2.764 |
| Novo Nordisk A/S | 5.000 |
Price to Book Value Related Metrics
| PE Ratio | 22.68 |
| PS Ratio | 5.839 |
| PEG Ratio | 0.0254 |
| Price to Free Cash Flow | 41.24 |
| Price | 149.57 |
| Earnings Yield | 4.41% |
| Market Cap | 57.03B |
| PEGY Ratio | 0.0253 |
| Operating PE Ratio | 18.34 |
| Normalized PE Ratio | 22.49 |